Cedars-Sinai Researcher lists PPHM in her Disclosures in this Joint Mem.Sloan/Cedars-Sinai AACR’17 Abstract, where she's the Lead Author, along with co-authors Jedd Wolchok, Taha Merghoub, and several other Mem. Sloan researchers. So, 2 of Dr. Wolchok’s 5 AACR’17 abstracts are Joint PPHM+MemSloan, and a 3rd is Joint CedarsSinai+MemSloan whereby the Lead Author lists Peregrine in her disclosures. Maybe we need to add Cedars-Sinai to our collabs list along with Memorial Sloan Kettering, Duke, MDA, Rutgers, ImmunoVaccine, and UTSW.
Digging a little further, found this article which has both authors advising Peregrine (see bottom of article). From the topic of their work, it would appear they are advisers to Peregrine for the breast-cancer trial design - JMO